Mario Plebani

Mario Plebani obtained his medical degree summa cum laude from the Medical School of the University of Padova. He completed residency training and specialization in Laboratory Medicine, and subsequently in Gastroenterology, at the same University. He is Honorary Professor of Clinical Biochemistry and Clinical Molecular Biology at the School of Medicine, University of Padova and Chief of the Department of Laboratory Medicine at the University-Hospital of Padova. In 2017 it was appointed Dean of the Medical School of the University of Padova and, from 1991 is the Chief of the Center of Biomedical Research (a specialized Center for quality in laboratory medicine for the Veneto Region). He was the Director of the Post-graduate course of Clinical Pathology and Clinical Biochemistry of the University of Padova. Honorary Professor at the University of Buenos Aires (Argentina), Facultad de Farmacia y Bioquimica and Appointment and “Adjunct Professor”, University of Texas Medical Branch (Department of Pathology). Currently, he covers the role of Scientific Manager of the Regional Coordination for the development of innovation of appropriateness and (biomedical) harmonization in Laboratory Medicine, Veneto Region, Italy. He served as President of the International Society of Enzymology for four years (2004-2008), as President of the Italian Society of Clinical Biochemistry and Molecular Clinical Biology for five years (in 2003 and from 2007 to 2009) and President of the Federation of Italian Societies of Laboratory Medicine (FISMeLAB) from 2009 to 2012. President-Elect dell’European Federation of Laboratory Medicine (EFLM) (2022/2023). Prof. Plebani is Editor-in-Chief of Clinical Chemistry and Laboratory Medicine, and Editor in Chief of Diagnosis. He has published 1509 full papers, more than 900 abstracts and several books and book chapters, HI 110 (20.351 citations with an average per year of 371 citations), and an Impact Factor of 984.495 in the last three year. Invited speakers at many national and international meetings and conferences such as the AACC annual meetings in 1998, 2005 and 2007-2012, the IFCC/EFCC International Congresses in Florence (1999), Kyoto (2002), the IFCC-FESSC EuroMedLab in Prague (2001), Barcelona (2003), Glasgow (2005), Innsbruck (2009), Berlin (2012) and Milan (2013). He has been invited as key-note speaker at many national meetings of IFCC member societies, including Australia, UK, Ireland, Spain, Switzerland, Belgium, Finland, Turkey, Chile, Argentina, Uruguay, Perù. Awards received: 1991-King Prize for achievement and original research in Clinical Enzymology, International Society for Clinical Enzymology (ISE); 2007-AACC Management Sciences Division, Outstanding Contributions to Management Sciences Award; 2008-AACC Award for Outstanding Clinical Laboratory Contributions to Patient Safety; 2011-ACB (UK) International Lecture Award, 2014-IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) Distinguished Award for Laboratory Medicine and Patient Care and 2014-AACC/NACB Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research and the 2014 Canadian Society (CSCC) “Travelling Lecture” Award; 2019- AACC 2019 Outstanding Contributions Through Service to the Profession of Clinical Chemistry Award. His main areas of research are quality management in laboratory medicine, diagnostic and laboratory errors, biomarkers in cancer and cardiovascular diseases, and in vitro allergy diagnostics.